Limoneira CEO says company isn’t looking to move
Santa Paula-based Limoneira is unlikely to leave the area if it sells some or all of the company as part of its strategic review, CEO Harold Edwards told the Business Times. “I just don’t see it,” he said during a Dec. 11 interview. “This isn’t about us leaving. This is about us figuring out how Read More →
Newmark completes $14.9M sale of Thousand Oaks building
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
A psychedelic renaissance: Lucid Therapeutics aims to heal mental wounds
For nearly two decades, Dr. Remi Drozd spent his life healing people’s physical pain as an emergency room physician on the East Coast. And while it brought him joy, it also left him thinking about the subsect of people he felt he couldn’t help quite as easily. “For 15 years I witnessed people going through Read More →
Tri-County experts see uptick in worker burnout
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Banc of California closes merger with PacWest, raises $400M
Los Angeles-based Banc of California announced the completion of its all-stock merger with PacWest Bancorp, which will take effect Dec. 1. Announced on Nov. 30, Pacific Western Bank, a subsidiary of PacWest Bancorp, has now merged into Banc of California meaning the combined bank will operate under the Banc of California name and brand. The Read More →
Acelyrin shares decline after programming error disclosure
Conejo Valley-based Acelyrin saw shares plummet more than 30% on Nov. 28 after the biotechnology startup announced an error in one of its trials for its main treatment. Acelyrin, which is a part of Westlake Village BioPartners investing portfolio, disclosed there was a programming error in a drug trial of izokibep, a treatment for psoriatic Read More →
Deckers shares skyrocket in month after earnings excitement
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
